Guardant Health
GH
#1530
Rank
โ‚น1.215 T
Marketcap
โ‚น9,357
Share price
2.11%
Change (1 day)
203.87%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

Guardant Health (GH) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : โ‚น146.52 Billion

According to Guardant Health 's latest financial reports the company's total liabilities are โ‚น146.52 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Guardant Health - Total liabilities on balance sheet (from 2017 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31โ‚น139.42 B2.89%
2023-12-31โ‚น135.50 B5.66%
2022-12-31โ‚น128.24 B10.49%
2021-12-31โ‚น116.07 B73.24%
2020-12-31โ‚น67.00 B720.32%
2019-12-31โ‚น8.16 B87.05%
2018-12-31โ‚น4.36 B99.2%
2017-12-31โ‚น2.19 B-12.5%
2016-12-31โ‚น2.50 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Natera
NTRA
โ‚น51.13 B-65.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Neogen
NEOG
โ‚น113.13 B-22.79%๐Ÿ‡บ๐Ÿ‡ธ USA